About
FREZENT Biological Solutions develops antibody therapies and antibody-drug conjugates that target dormant cancer cells to prevent cancer recurrence, initially focusing on head and neck cancer and expanding to osteosarcoma and pancreatic cancer.
Explore FREZENT Biological Solutions's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.